CClinicalTrials.gg
CompletedNCT07389317Updated Feb 5, 2026

Assessing Illustrated Medication Labels

An interventional study of standard medication label and Illustrated medication label in Health Behavior, Medication Adherence and Understanding of Medication Instructions, sponsored by Wayne Sanderson. Completed at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-05.

Sponsored by Wayne Sanderson · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled May 2025, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
87
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate the impact of graphic-based medication labels on medication understanding and to assess the health literacy of our farmworker population. The main questions it aims to answer are:

Primary Objective: Assess the impact of illustrated medication labels on medication understanding among migrant and seasonal farmworkers Secondary Objective: Evaluate the health literacy of the farmworker population in South Georgia

Participants will be given either medication labels with pictures or standard medication labels

02

Conditions studied

  • Health Behavior
  • Medication Adherence
  • Understanding of Medication Instructions
03

In context

Health Behavior

228 studies on the registry are indexed under Health Behavior; 95 are open to participants now.

This study's enrollment of 87 is below the median of 114 across 196 interventional studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

This is the only study on the registry with Wayne Sanderson as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults aged 18 and older
  • Receiving medication education at Emory Farm Worker Project (EFP) clinics

Exclusion criteria

Exclusion Criteria:

  • Individuals unable to provide informed consent or participate in the study
  • Those not requiring medication during their visit
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
87 participants (actual)

Study arms

  • Active comparator
    Standard medication label

    Behavioral: standard medication label

  • Experimental
    Illustrated medication label

    Behavioral: Illustrated medication label

Interventions

  • Behavioralstandard medication label

    Standard Education Procedure: Based on best practices, including simple, standardized instructions in the participants' native language and the "teach-back" method.

  • BehavioralIllustrated medication label

    Illustrated medication labels: Labels will include visuals for medication name, time of administration, food interactions, indications, and potential side effects

06

What researchers measure

Primary outcomes

  1. Medication Understanding Questionnaire (MUQ)

    MUQ will assess participants' understanding of their medications after education. Scores range from 0-3 to test medication purpose, dose, and frequency

    Time frame: Post intervention (10 minutes)

Secondary outcomes

  1. Brief Health Literacy Screen (BHLS)

    The BHLS consists of 4 questions with each item being worth 1-5 points. Total score range from 4-20 with higher score equating to greater health literacy

    Time frame: Post intervention (10 minutes)

07

Study locations

2 sites
  • Emory University
    Atlanta, Georgia 30322, United States
  • University of Kentucky
    Lexington, Kentucky 40506, United States
08

References and documents

Study documents

  • Informed consent form · Sep 3, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07389317
Lead sponsor
Wayne Sanderson
Responsible party
Wayne Sanderson (Professor, University of Kentucky) — Sponsor-investigator
First posted
Feb 5, 2026
Start date
May 17, 2025
Primary completion
May 22, 2025
Completion
May 22, 2025
Last update
Feb 5, 2026

Study contacts

Jodie Guest, PhD
principal investigator · Emory University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion